0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-69.16%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
No Data
No Data available this quarter, please select a different quarter.
-0.57%
Negative EPS growth while 0425.HK is at 5.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-0.57%
Negative diluted EPS growth while 0425.HK is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.24%
Slight or no buybacks while 0425.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.24%
Slight or no buyback while 0425.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13337.02%
10Y revenue/share CAGR above 1.5x 0425.HK's 310.12%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
18269.76%
5Y revenue/share CAGR above 1.5x 0425.HK's 310.12%. David Dodd would look for consistent product or market expansions fueling outperformance.
22547.88%
3Y revenue/share CAGR above 1.5x 0425.HK's 189.32%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
273.40%
10Y OCF/share CAGR under 50% of 0425.HK's 661.19%. Michael Burry would worry about a persistent underperformance in cash creation.
365.22%
5Y OCF/share CAGR at 50-75% of 0425.HK's 661.19%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
10.20%
3Y OCF/share CAGR under 50% of 0425.HK's 61.37%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
286.47%
Net income/share CAGR 1.25-1.5x 0425.HK's 241.49%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
316.47%
5Y net income/share CAGR 1.25-1.5x 0425.HK's 241.49%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
857.76%
3Y net income/share CAGR above 1.5x 0425.HK's 157.35%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.65%
We cut SG&A while 0425.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.